<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T15:51:08.6069652+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-COG-C-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Project to continue improving the national response to HIV in the areas of prevention, care and support, and to strengthen the response to Tuberculosis in Congo - Congo (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Congo, TB/HIV, United Nations Development Programme (UNDP)This program has the following goals: VIH-But-1: Accélérer la réponse nationale et renforcer l’efficience et la performance des programmes en vue de mettre fin à l’épidémie du VIH en tant que menace de santé publique d’ici à fin 2030 / HIV-Goal-1: Accelerate the national response and strengthen program efficiency and performance to end the HIV epidemic as a public health threat by the end of 2030.  TB-But-1: Réduire l’incidence de la tuberculose de 370 cas pour 100 000 habitants en 2021 à 353 cas pour 100 000 habitants en 2027 /  TB-Goal-1: Reduce the incidence of TB from 370 cases per 100,000 population in 2021 to 353 cases per 100,000 population in 2027.  TB-But-2 : Réduire le taux de mortalité lié à la tuberculose de 54 décès pour 100,000 habitants en 2021 à 42 décès pour 100 000 habitants en 2027. /  TB-Goal-2: Reduce the TB mortality rate from 54 deaths per 100,000 population in 2021 to 42 deaths per 100,000 population in 2027..  TB-But-3 : Renforcer la gouvernance du programme national de lutte contre la tuberculose. /  TB-Goal-2: Reduce the TB mortality rate from 54 deaths per 100,000 population in 2021 to 42 deaths per 100,000 population in 2027.. The objectives of this program are: Objectif-VIH-1: Les nouvelles infections à VIH sont réduites à moins 50% d'ici fin 2027./ Objective- VIH-1: New HIV infections are reduced to less than 50% by the end of 2027.  Objectif-VIH-2: D’ici fin 2027, la mortalité liée au VIH/sida est réduite d'au moins 30% par rapport au niveau de 2022./  Objective-VIH-2: By the end of 2027, HIV/AIDS-related mortality is reduced by at least 30% compared to the 2022 level.  Objectif-VIH-3: Les obstacles liés aux droits humains et aux inégalités de genre entravant l’accès des populations clés et vulnérables aux services de prévention, de dépistage et de prise en charge du VIH sont réduits./ Objective-VIH-3: Human rights and gender barriers to accessing HIV prevention, testing and care services for key and vulnerable populations are reduced.  Objectif-VIH-4: Les systèmes de gestion, de suivi évaluation, de coordination et de gouvernance sensible au genre et inclusifs de la réponse au VIH sont renforcés et résilients durant la période 2023- 2027./ Objective-VIH-4: Gender-responsive and inclusive management, monitoring and evaluation, coordination and governance systems of the HIV response are strengthened and resilient during the period 2023-2027.  TB-Objectif-1: Faire passer la couverture du traitement de 55% en 2021 à 90 % en  / TB-Objective-1: Increase treatment coverage from 55% in 2021 to 90% in 2027.  TB-Objectif-2 : Traiter 21 368 patients, d’ici à 2027 avec un succès de traitement au moins 90 %./ TB-Objective-2 :Treat 21,368 patients by 2027 with at least 90% treatment success.  TB-Objectif-3 : Faire passer à 100 % d’ici à 2027, la couverture de l’enregistrement et de la notification fiables des données concernant la tuberculose. / TB-Objective-3 :Increase coverage of reliable TB data notification and reporting to 100% by 2027.  TB-Objectif-4 : Atteindre 70% d’ici à 2027 la couverture de l’appui social apporté aux personnes atteintes de tuberculose pharmacosensible conformé bacteriologiquement remplissant les conditions requises et 100% des patients atteintes de tuberculose pharmacoresistante. / TB-Objective-4 :Achieve 70% coverage of social support for eligible drug-susceptible TB patients and 100% of drug-resistant TB patients by 2027</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="COG-C-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Lionel, CARUANA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>lionel.caruana@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="CG" percentage="100">
			<narrative xml:lang="en">Congo</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="54">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="25">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="19">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for AGYW and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Removing human rights-related barriers to prevention for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced disease (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="25">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="24">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">9937773.79</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">8514505.12</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-01-01">13740162.77</value>
		</budget>
		<transaction ref="80e8c71d-714a-4f48-a516-5ad7497bb97b">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-11-04" />
			<value currency="USD" value-date="2025-11-04">11768392.77</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="63b55a9b-2cc2-4fbf-9ad9-d9e4943ca063">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-13" />
			<value currency="USD" value-date="2023-12-13">13553968.40</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1ef9fc57-fe18-4c82-b2f7-baf6cdecae53">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-17" />
			<value currency="USD" value-date="2024-12-17">2949980.13</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4b9e61b7-ca72-4c18-a768-a2e78c135b3c">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-10-17" />
			<value currency="USD" value-date="2024-10-17">3239965.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="64d6644d-ec92-41fe-857f-f04a7dda72fb">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-11-11" />
			<value currency="USD" value-date="2025-11-11">5049126.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8e201cc7-3021-46b5-8ae9-ffde4e60a827">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-19" />
			<value currency="USD" value-date="2023-12-19">5001036.48</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b2d249d3-616a-4aaf-8335-65f687961759">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-06-11" />
			<value currency="USD" value-date="2025-06-11">2362986.56</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/COG-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for COG-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="70.00" />
					<actual value="81.42" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="85.00" />
					<actual value="85.53" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="75.00" />
					<actual value="85.84" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="55.00" />
					<actual value="53.37" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="56.01" />
					<actual value="53.19" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="8351" />
					<actual value="7141" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of high risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="40.00" />
					<actual value="16.89" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who completed TPT out of those who initiated TB preventive treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="60.00" />
					<actual value="57.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="76.50" />
					<actual value="84.15" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="27.00" />
					<actual value="19.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="31.18" />
					<actual value="31.22" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="32.00" />
					<actual value="32.23" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="70.00" />
					<actual value="69.99" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="173" />
					<actual value="120" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="14.94" />
					<actual value="9.97" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="83.00" />
					<actual value="80.15" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="20.00" />
					<actual value="79.77" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="20.57" />
					<actual value="24.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="100.00" />
					<actual value="97.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="85.00" />
					<actual value="84.27" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="7.48" />
					<actual value="8.24" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="657" />
					<actual value="742" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of pregnant women who know their HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="18.86" />
					<actual value="21.48" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-COG-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Project to improve the national response to HIV in the areas of prevention, care and support and to strengthen the response  to tuberculosis in Congo  - Congo (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Congo, TB/HIV, United Nations Development Programme (UNDP)This program has the following goals: Réduire de 50% les nouvelles infections parmi les populations vulnérables (en l’occurrence les jeunes filles, les jeunes femmes), les populations clés et éliminer celles chez les enfants d'ici à 2023/Reduce new infections by 50% among vulnerable populations (young girls, young women), key populations and elimination among children by 2023.  Réaliser les objectifs 90-90-90 en vue de réduire de manière significative la morbidité et la mortalité chez les PVVIH  d'au moins 62% d'ici à 2023/Achieve the 90-90-90 targets to significantly reduce morbidity and mortality among PLHIV by at least 62% by 2023.  Réduire le nombre de décès lié à la tuberculose de 35% à l'horizon 2023 par rapport à l'année 2015/Reduce the number of tuberculosis-related deaths by 35% by 2023 compared to 2015.  Réduire l'incidence de la tuberculose de 20% à l'horizon 2023 par rapport à 2015/Reduce the incidence of tuberculosis by 20% by 2023 compared to 2015. The objectives of this program are: Augmenter la proportion des personnes vivant avec le VIH qui connaissent leur statut sérologique à 65% en 2023/Increase the proportion of people living with HIV who know their HIV status to 65% between 2021 and 2023.  Augmenter la proportion des femmes enceintes séropositives qui ont accès à la TAR à 50 % d'ici à 2023/Increase the proportion of pregnant women with HIV who have access to ART to 50% by 2023.  Augmenter la proportion des personnes séropositives qui ont accès à la TARV à 40% d'ici à 2023/Increase the proportion of people living with HIV who have access to ART to 40% by 2023.  Augmenter la proportion des personnes sous TARV qui ont leur charge virale indetectable à 70% d'ici à 2023/Increase the proportion of people on ART who have their undetectable viral load to 70% by 2023.  Accroître de 20% d'ici 2023 la notification de nouveaux cas et rechutes de tuberculose toutes formes par rapport à 2015/Increase to 20% by 2023 the notification of new  and relapses cases of all forms of tuberculosis compared to 2015.  Atteindre 70% de taux de sucès thérapeutique chez les nouveaux cas et rechutes de tuberculose toutes formes d'ici 2023/Achieve 70% treatment success rate in new  and relapses cases of all forms of tuberculosis by 2023.  Atteindre 80% de taux de succès thérapeutique chez les malades multi-résistants mis sous traitement de 2ème ligne d'ici 2023/Achieve 80% treatement success rate inMDR-TB patients on second line treatment by 2023</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="COG-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Lionel, CARUANA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>lionel.caruana@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="CG" percentage="100">
			<narrative xml:lang="en">Congo</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="32">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="51">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="4">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="13">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Community empowerment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="25">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="12">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Health products and waste management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Laboratory systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for TB programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk mitigation for disease programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; RSSH/PP: Community health workers: Integrated supportive supervision</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="17">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Information systems and integrated specimen transport networks</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Infrastructure and equipment management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">11608214.90</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2021-01-01">5297420.77</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">10021547.59</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2021-01-01">3813237.47</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">17884783.90</value>
		</budget>
		<transaction ref="ab220a23-0c4f-4512-932b-37cca2560038">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-1301218.77</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c2e33aa4-2d16-4135-b309-a80b59267b33">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-10" />
			<value currency="USD" value-date="2024-12-10">6788180.67</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6cd474f1-34c6-43f9-972e-3f96154d420b">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-10" />
			<value currency="USD" value-date="2024-12-10">-2182952.63</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="eab53080-af8a-4d3d-be80-69c3334d55b9">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-05-23" />
			<value currency="USD" value-date="2023-05-23">0.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c7346225-8b4d-4e83-9f6f-9d16ddaaa9fc">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-28" />
			<value currency="USD" value-date="2024-06-28">3479741.91</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="45560c12-4403-4700-a0ca-f5d78bd911a8">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-13658.37</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0b0cd739-0a37-4f15-8948-12f3bbb506a1">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-04" />
			<value currency="USD" value-date="2024-06-04">-24740.80</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a7a7e4ad-4ab6-4369-963c-ad49399332bc">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-11-21" />
			<value currency="USD" value-date="2023-11-21">3625506.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="51fa1d85-a9b1-4cd9-a8bb-fb72823600d1">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-23" />
			<value currency="USD" value-date="2023-07-23">24740.80</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1cabc5ad-73d1-4508-b79c-3905ddd4fba3">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-10" />
			<value currency="USD" value-date="2024-06-10">-25348.81</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0911a845-a066-4ad4-b200-fd2a2c49ce29">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-03-20" />
			<value currency="USD" value-date="2023-03-20">25809.30</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7e2d7f31-8d30-4d0c-940b-3ba130e95efc">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-05-23" />
			<value currency="USD" value-date="2023-05-23">-1316086.19</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ca9adaf2-63ea-4d8d-bad1-adff5be430d8">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-01-11" />
			<value currency="USD" value-date="2021-01-11">19245261.91</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5c42d3b7-0f5f-4657-bf9e-b27f5fdd32da">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-24" />
			<value currency="USD" value-date="2022-02-24">47650.69</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="61830b23-2659-4d29-b088-d1befc9ac236">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-04" />
			<value currency="USD" value-date="2024-06-04">25348.81</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="55b55264-feb7-4af0-bbca-fe32c91a29be">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-08" />
			<value currency="USD" value-date="2023-06-08">12258853.87</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="77d15209-dd37-401f-990c-f00d1eca56da">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-04" />
			<value currency="USD" value-date="2024-06-04">-608.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5322ab3c-0b6c-495a-b4b6-233964067ff8">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-03-20" />
			<value currency="USD" value-date="2023-03-20">-23053.27</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="57f22c59-b5fa-4e7d-84f8-4f0273b8cccf">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-03-20" />
			<value currency="USD" value-date="2023-03-20">-2756.02</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="52292355-27cd-4eac-9be5-555318ebccf2">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-06-30" />
			<value currency="USD" value-date="2022-06-30">4211225.43</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="524c1c01-a13f-4c21-80a5-550c06695a3b">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-11-21" />
			<value currency="USD" value-date="2023-11-21">-194942.29</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="021dee14-8f25-45b9-aa5e-3f4fdc684bed">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-13658.37</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d5edac54-a019-466e-977e-a9b108e58207">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-25" />
			<value currency="USD" value-date="2021-11-25">4982976.89</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="15be2038-e8e2-4117-b5c7-cdb94a2233c6">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-13" />
			<value currency="USD" value-date="2023-06-13">1057166.39</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fea40c3b-cf30-44c6-bf09-5eee8b6a5f14">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-05" />
			<value currency="USD" value-date="2023-10-05">3859511.39</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="18507c27-99f4-472a-bb2c-496c69ba9ba9">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-13" />
			<value currency="USD" value-date="2024-12-13">1822166.04</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4ea0528f-2eb2-4c87-bb87-842a4810ab89">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-1301218.77</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6cced64f-eb79-4460-b23f-50454fbdd7ed">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-05" />
			<value currency="USD" value-date="2023-10-05">1227311.53</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8823156a-95e6-4ba0-8d5d-477c0fcabb68">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-07-07" />
			<value currency="USD" value-date="2022-07-07">2895139.25</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a027d0f7-d03e-4b01-8fc8-748cc6239921">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-10-14" />
			<value currency="USD" value-date="2025-10-14">3860365.08</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="064fad3c-f983-4906-bb6a-728e83e9c1b4">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-11-23" />
			<value currency="USD" value-date="2023-11-23">2062568.21</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aa8e62dc-016c-44e6-a2c0-0971b1f79061">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-14" />
			<value currency="USD" value-date="2023-03-14">25809.30</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3705bb91-95a9-4648-bf08-5702bc3be19a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-11-23" />
			<value currency="USD" value-date="2023-11-23">1562937.88</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7c31ef60-a212-4c6e-a954-f8f7cd67fe32">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-03-01" />
			<value currency="USD" value-date="2022-03-01">24597.42</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="000735f3-bb77-40c0-8dda-5d626488511c">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-06-09" />
			<value currency="USD" value-date="2022-06-09">5932164.56</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bcef9ae6-451b-43e7-8489-d167c01749fa">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-07-02" />
			<value currency="USD" value-date="2024-07-02">1296789.28</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a1e2affe-a30e-4c9a-a686-84f1e5b7e30e">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-01-20" />
			<value currency="USD" value-date="2021-01-20">8330120.45</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4bbf2c35-531a-4695-a87f-dbd0c4bd950f">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-06-13" />
			<value currency="USD" value-date="2023-06-13">5919922.26</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COG-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/COG-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for COG-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="33.00" />
					<actual value="28.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="40.00" />
					<actual value="32.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="36.00" />
					<actual value="30.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="32.00" />
					<actual value="27.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="37.00" />
					<actual value="31.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="40.00" />
					<actual value="32.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="36.00" />
					<actual value="30.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="32.00" />
					<actual value="27.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="29.00" />
					<actual value="25.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="82.00" />
					<actual value="26.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="82.00" />
					<actual value="72.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="85.00" />
					<actual value="91.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="94.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="93.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="82.00" />
					<actual value="117.60" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="300" />
					<actual value="206" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="103" />
					<actual value="66" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="126" />
					<actual value="134" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="103" />
					<actual value="69" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="253" />
					<actual value="213" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="150" />
					<actual value="96" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="150" />
					<actual value="110" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="206" />
					<actual value="135" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="127" />
					<actual value="79" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="25.00" />
					<actual value="80.70" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="30.00" />
					<actual value="48.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="30.00" />
					<actual value="41.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="40.00" />
					<actual value="55.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="25.00" />
					<actual value="36.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="25.00" />
					<actual value="27.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="30.10" />
					<actual value="45.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="40.00" />
					<actual value="52.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="40.00" />
					<actual value="49.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="23.60" />
					<actual value="10.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="23.60" />
					<actual value="14.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="24.00" />
					<actual value="23.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="23.60" />
					<actual value="18.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="21.70" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="21.70" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="24.00" />
					<actual value="22.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="24.00" />
					<actual value="21.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="90.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="87.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="90.00" />
					<actual value="95.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="91.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="73.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="72.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="71.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="88.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.00" />
					<actual value="69.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="84.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="81.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="64.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="85.00" />
					<actual value="63.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="75.00" />
					<actual value="51.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="78.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.00" />
					<actual value="77.70" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="88.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="7950" />
					<actual value="6838" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="8260" />
					<actual value="5839" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="5506" />
					<actual value="6140" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="6504" />
					<actual value="6673" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="13766" />
					<actual value="11979" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="15177" />
					<actual value="14370" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="14454" />
					<actual value="13511" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="7892" />
					<actual value="7273" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="7285" />
					<actual value="7097" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="300" />
					<actual value="228" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="253" />
					<actual value="215" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="127" />
					<actual value="80" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="103" />
					<actual value="69" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="206" />
					<actual value="134" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="126" />
					<actual value="135" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="103" />
					<actual value="65" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="150" />
					<actual value="116" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="150" />
					<actual value="112" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="56.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="77.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="50.00" />
					<actual value="54.50" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="55.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="80.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="56.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="42.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="29.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="83.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="70.00" />
					<actual value="72.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="78.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="78.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="78.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="76.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="75.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="84.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="80.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="77.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.10" />
					<actual value="46.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="68.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="65.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="70.00" />
					<actual value="29.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="75.00" />
					<actual value="62.50" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="75.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="65.00" />
					<actual value="56.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="65.00" />
					<actual value="56.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.00" />
					<actual value="64.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of health facilities providing diagnostic services with tracer items available on the day of the visit or day of reporting</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="70.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="23.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="23.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="98.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="94.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="98.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="97.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.40" />
					<actual value="91.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="82.00" />
					<actual value="111.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="82.50" />
					<actual value="66.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="82.00" />
					<actual value="21.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="85.00" />
					<actual value="86.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="88.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="28.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="90.00" />
					<actual value="30.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="88.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="29.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="54.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="33.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="88.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="74.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">LAB-Other1 : Percentage of laboratories showing adequate performance in external quality assurance for HIV viral load among the total number of laboratories that undertake HIV viral load during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="75.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="75.00" />
					<actual value="50.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="65.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.00" />
					<actual value="37.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.00" />
					<actual value="27.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="75.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="70.00" />
					<actual value="18.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="62.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="65.00" />
					<actual value="34.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="65.00" />
					<actual value="34.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="55.00" />
					<actual value="11.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="30.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="21.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="50.00" />
					<actual value="1.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="35.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="50.00" />
					<actual value="6.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="50.00" />
					<actual value="12.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="35.00" />
					<actual value="0.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="25.00" />
					<actual value="14.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="40.00" />
					<actual value="19.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="22.00" />
					<actual value="11.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="10.00" />
					<actual value="1.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="18.00" />
					<actual value="8.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="26.00" />
					<actual value="11.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="29.00" />
					<actual value="12.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="24.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="15.00" />
					<actual value="12.80" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for COG-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.50" />
					<actual value="2.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.50" />
					<actual value="2.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.50" />
					<actual value="2.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="42" />
					<actual value="46" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="42" />
					<actual value="46" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="369" />
					<actual value="370" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="367" />
					<actual value="369" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="365" />
					<actual value="369" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="79" />
					<actual value="132" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="65" />
					<actual value="134.34" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for COG-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="81.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="40.36" />
					<actual value="25.38" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="45.00" />
					<actual value="24.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="65.00" />
					<actual value="73.34" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="84.07" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="82.65" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="66.00" />
					<actual value="54.45" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="71.00" />
					<actual value="62.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="69.00" />
					<actual value="62.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of women aged 15-19 who have had a live birth or are currently pregnant</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="3.40" />
					<actual value="3.07" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.80" />
					<actual value="1.77" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>